Company / Revenue
LEXICON PHARMACEUTICALS, INC. Revenue History
FY2013-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$1.2M
FY2025
5-year range
$139.0K / $79.3M
FY2021-FY2025
Trend
+766.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue changed +766% YoY in FY2025, a notable deviation from the 9-year average annual change of +218%.
Based on SEC 10-K filings.
$1M in FY2025 with a 10-year CAGR of -5.9%.
Improved from $298,000 to $1M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -5.9%
Key checks
Key Insights
- In FY2025, revenue increased 766.2% year-over-year.
- Peak revenue was recorded in FY2017.
- Lowest revenue in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -1.98 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.2M | +766.2% |
| FY2024 | $139.0K | -53.4% |
| FY2023 | $298.0K | -98.8% |
| FY2019 | $24.0M | -69.7% |
| FY2018 | $79.3M | -39.0% |
| FY2017 | $130.0M | +468.9% |
| FY2016 | $22.9M | +928.5% |
| FY2015 | $2.2M | +104.0% |
| FY2014 | $1.1M | -41.1% |
| FY2013 | $1.8M | -62.3% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026